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In aging individuals, both protective as well as regulatory immune functions are declining, 
resulting in an increased susceptibility to infections as well as to autoimmunity. Nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase 2-deficiency in immune cell subsets 
has been shown to be associated with aging. Using intravital marker-free NAD(P)
H-fluorescence lifetime imaging, we have previously identified microglia/myeloid cells 
and astrocytes as main cellular sources of NADPH oxidase (NOX) activity in the CNS 
during neuroinflammation, due to an overactivation of NOX. The overactivated NOX 
enzymes catalyze the massive production of the highly reactive O
−
2 , which initiates in 
a chain reaction the overproduction of diverse reactive oxygen species (ROS). Age-
dependent oxidative distress levels in the brain and their cellular sources are not known. 
Furthermore, it is unclear whether in age-dependent diseases oxidative distress is initi-
ated by overproduction of ROS or by a decrease in antioxidant capacity, subsequently 
leading to neurodegeneration in the CNS. Here, we compare the activation level of NOX 
enzymes in the cerebral cortex of young and aged mice as well as in a model of vascular 
amyloid pathology. Despite the fact that a striking change in the morphology of microglia 
can be detected between young and aged individuals, we find comparable low-level 
NOX activation both in young and old mice. In contrast, aged mice with the human 
APPE693Q mutation, a model for cerebral amyloid angiopathy (CAA), displayed increased 
focal NOX overactivation in the brain cortex, especially in tissue areas around the ves-
sels. Despite activated morphology in microglia, NOX overactivation was detected only 
in a small fraction of these cells, in contrast to other pathologies with overt inflammation 
as experimental autoimmune encephalomyelitis (EAE) or glioblastoma. Similar to these 
pathologies, the astrocytes majorly contribute to the NOX overactivation in the brain 
cortex during CAA. Together, these findings emphasize the role of other cellular sources 
of activated NOX than phagocytes not only during EAE but also in models of amyloid 
pathology. Moreover, they may strengthen the hypothesis that microglia/monocytes 
show a diminished potential for clearance of amyloid beta protein.
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inTrODUcTiOn
Following the free-radical theory of aging, reactive oxygen spe-
cies (ROS) are massively produced, e.g., >100  nM H2O2, and 
attack their targets in the organism randomly, indiscriminative 
and cumulative, thus, generating oxidative distress (1). Oxidative 
distress is a general term for the dysfunction of signaling and 
defense mechanisms based on ROS.
As several ROS are highly reactive, their localization is cru-
cial for the resulting effects: on the one hand, ROS act as specific 
signaling molecules intracellularly at ~1–10 nM concentration, 
on the other hand, they constitute effective extracellular host 
defense mechanisms at concentrations over 100 nM. Since the 
organism has efficient mechanisms to neutralize high ROS 
concentrations, e.g., via glutathione peroxidase or superoxide 
dismutase (2), these phenomena are physiological and can 
be summarized under the term “oxidative eustress” (1). The 
enzymes of the nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase family, consisting of NOX1, NOX2 (phox), 
NOX3, NOX4, DUOX1, DUOX2 (3), are central players lead-
ing both to oxidative eustress and distress. Their activation 
catalyzes the oxidative burst when abundant highly reactive O2
− 
is produced by oxidation of molecular oxygen. Under enzymatic 
catalysis, O2
− reacts with various small molecules leading to 
massive ROS production. When this massive ROS production 
exceeds the capacities of antioxidant defense mechanisms of the 
tissue or when extracellular highly reactive ROS species such as 
H2O2 enter the cells via peroxiporins such as AQP8 (4), oxida-
tive distress occurs, leading to tissue dysfunction and damage. 
It is assumed that oxidative distress responsiveness is linked to 
aging. However, this hypothesis is mainly funded on genetic 
studies (5), which allow conclusions on the expression levels, 
but not on the actual activation of these central enzymes.
Here, we focus on NADPH oxidase enzyme activation levels 
in the brain, as this organ is especially vulnerable to oxidative 
distress. There is evidence that the aged brain is more susceptible 
to injuries (6). This is mainly attributed to a so-called activated 
basal state of low-grade chronic inflammation that has been 
called “inflamm-aging” (7). Low-grade inflammation in aging 
is also associated with microgliosis; however, the function of 
microglia in this process is highly discussed as studies using cell 
morphology, protein expression, cellular dynamics, or ex vivo 
cytokine production could detect age-dependent differences (8). 
No information on the age-dependent oxidative distress levels 
and their cellular sources in situ are available.
In this study, we determine NADPH oxidase activation levels 
in the context of amyloid pathology, in order to investigate 
age-dependent, immune-mediated tissue damaging mecha-
nisms in neurodegenerative diseases. We hypothesize that an 
age-dependent dysregulation of immune responses in the CNS 
contributes to neuroinflammatory processes associated with 
neurodegeneration. ROS have been implicated in mediating 
age-dependent changes and promoting age-dependent neuro-
degeneration (9). Recently, oxidative distress has been regarded 
as an early sign of Alzheimer’s disease (AD) pathophysiology, 
although the source of ROS and the mechanisms how amy-
loid peptides (Aβ) influence oxidative distress have not been 
adequately investigated (10). Subunits of NOX2 are upregu-
lated in patients with mild cognitive impairment compared to 
normal age-matched controls. During disease progression, a 
further increase of the cytosolic subunits p67phox, p47phox, 
and p40phox could be detected in the CNS tissue. In addition, 
there was a robust correlation between NOX subunit expres-
sion and the individual’s cognitive status (11). Together, this 
suggests that increases in NOX activity participate in early AD 
pathogenesis and contribute to AD progression due to massive 
ROS production initiated by NADPH oxidases, activating 
signaling pathways leading to neuronal excitotoxicity and glial 
cell-mediated inflammation (12).
Although many studies claim to analyze NOX activity, 
only limited information can be gained based on the analysis 
of subunit expression levels. The quantification of ROS levels 
in tissue has been widely used. However, the highly diffusive 
nature of ROS does not allow to draw conclusions on their 
origin in tissues. Up to now, neither the catalytic activity of 
NOX enzymes leading to oxidative distress nor their cellular 
sources could be tracked in vivo. We therefore use our previ-
ously published marker-free method of intravital fluorescence 
lifetime imaging (FLIM) of NAD(P)H (13) to analyze the 
distribution and cellular source of NADPH oxidase activation 
(14, 15). Since activated NOX enzymes are membrane-bound 
and can be detected by FLIM, this technique allows for an 




For intravital imaging, a frontoparietal cranial window prepara-
tion was performed and the dural layer was removed according 
to previous publications (16). Both fluorescence intensity and 
FLIM experiments were performed as previously described 
with a two-photon laser-scanning microscope based on a 
commercial scan head (TriMScope, LaVision BioTec, Bielefeld, 
Germany). All images are acquired in 30–150 µm depth within 
the frontoparietal cortex (z-step =  2  µm). Ten imaging fields 
per mouse were acquired, and the fields of vision with the 
highest NOX enzyme activation in every group were included 
into analysis. The detection of the fluorescence signals was 
accomplished either with photomultiplier tubes in the ranges 
460 ± 30, 525 ± 25, 593 ± 20 nm or with a 16-channel paral-
lelized TCSPC detector (FLIM-X16, LaVision BioTec, Bielefeld, 
Germany) in the range 460 ± 30 nm. The excitation of NADH 
and NADPH [hereafter collectively referred to as NAD(P)H] 
was performed at 760 nm (detection at 460 ± 30 nm). Dextran–
rhodamine (detection at 593 ±  20  nm) and EGFP (detection 
at 525 ± 25 nm) were excited at 850 or 880 nm. For intensity 
and FLIM, we used an average maximum laser power of 8 mW. 
The experimental parameters for FLIM were 80 ps histogram 
bin [for NAD(P)H-FLIM] and maximum acquisition time 
for a 512 × 512 image was 5 s to record a fluorescence decay 
stack. The time-window in which the fluorescence decays were 
acquired was set to 9 ns.
Table 1 | Overview of NOX activation from individual mice analyzed.



























1–4 imaging fields were analyzed per mouse. NOX activation represents mean values.
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Data analysis
Fluorescence lifetime imaging data analysis was carried out with 
self-written software, as previously described (14, 15). We used a 
bi-exponential decay function (Eq. 1):
 I t e ea a
t t
NAD P H( )
τ( ) ε += ⋅ ⋅+− −1 21 2
/ /τ
 (1)
with ɛ the background, the 1-indexed term of the sum represent-
ing the fluorescence decay of free NADH and NADPH, and the 
2-indexed term representing the fluorescence decay of enzyme-
bound NAD(P)H. The fluorescence lifetime τ1 [free NAD(P)H] is 
400–450 ps, while the fluorescence lifetime τ2 of NAD(P)H bound 
to metabolic enzymes has an average of ~2,000 ps and of 3,650 ps if 
bound to an enzyme of the NOX family. We focused in this study 
on the fluorescence lifetime τ2, of the enzyme-bound NAD(P)H. As 
previously described (14), we calculated the area of NOX activation 
within a τ2 image as the percentage of pixels having fluorescence life-
times between 3,300 and 3,900 ps as compared to the total number 
of pixels displaying fluorescence lifetimes between 0 and 10,000 ps.
In order to quantify microglial ramification in young and old 
Iba1:GFP mice from immunofluorescence data, we used our previ-
ously published algorithm based on discrete Fourier coefficients 
(17). Briefly, single microglia cells were segmented from the green 
channel of the immunofluorescence data acquired in the cortex 
of healthy 6 or 20  months old Iba1:GFP mice. Their shape was 
approximated by overlapping circles—the first centered in the 
center of the cell and the others centered on the periphery of the 
previous circle. Each layer of circles is mathematically characterized 
by a scalar parameter called Fourier coefficient. The first Fourier 
coefficient represents the position of the cell, the second defines its 
dimensions by approximating it with a sphere, and the next coef-
ficients define the degree of ramification of the cellular processes.
Statistical analysis and graphical presentation was performed 
with GraphPad Prism 4 (GraphPad Software, USA) and OriginPro 
(OriginLab, USA). Results are shown as mean values from the 
analyzed imaging fields (±SD) per group.
Mice
APPE693Q i.v. labeled with sulforhodamine 101 (for astrocyte staining 
in vivo) or APPE693Q:Iba-1-EGFP mice (18, 19) hemizygous for both 
genes were generated and maintained on a C57BL/6J background. 
Littermates with wild-type murine APP were used as controls. 
Groups of n ≥ 3 mice were used in all in vivo experiments and also 
for postmortem histological analysis, n ≥ 3 mice per group were 
used. Young mice were 6 months old and aged mice were between 
18 and 24 months old at time of analysis (in APP mutant and wild-
type group; individual mouse age listed in Table 1). Animals were 
group housed in standard cages under pathogen-free conditions on 
a 12-h light/dark cycle with food and water ad libitum. All animal 
experiments were performed in accordance to the national animal 
protection guidelines approved by the regional veterinary office for 
health and social services in Berlin (LaGeSo Berlin).
Murine Tissue Processing and 
immunofluorescence histology
After each intravital microscopy experiment, the brains of the 
mice were prepared for immunofluorescence by perfusion with 4% 
paraformaldehyde. The tissue was embedded in Tissue Tek (Sakura), 
frozen in a methylbutane/dry ice mixture into 10- or 30-µm sec-
tions using a cryostat. Sections were stained with goat anti-EGFP 
(Rockland, conjugated at the DRFZ to Alexa®488), mouse anti-
GFAP-Alexa®488 (eBioscience, Germany), rabbit anti-Noxo-1 
(Novus Biologicals, Germany), or goat anti-p47 (Abcam, Germany). 
Secondary antibodies used were donkey anti-rabbit Alexa®647 (Life 
Technologies, Germany) or donkey anti-goat-Alexa®647. Slides were 
analyzed on a Zeiss LSM 710 confocal system. Co-localization was 
analyzed by standardized background subtraction and subsequently 
multiplying the Noxo1 and GFAP channel using with Fiji Software.
human Tissue Processing and 
immunofluorescence histology
Brain samples were obtained from the Department of Neuro-
pathology, Charité – Universitätsmedizin Berlin. We included 
only anonymized individuals with cerebral amyloid angiopathy 
(CAA). The study was approved by the local ethics committee 
under the number EA1/078/16. Paraffin-embedded brain tissues 
were sectioned at 4 µm with a microtome (Microm HM330, GMI), 
followed by deparaffinization and rehydration in a decreasing 
ethanol series. For immunofluorescence staining, sections were 
blocked with 10% normal serum (NS) for 1  h. After washing, 
sections were incubated with primary antibodies mouse a-hu 
HLA-DR 1:100 (Dako), goat a-hu p47phox 1:100 (Abcam), rabbit 
a-GFAP (DAKO) 1:2,000, and mouse a-oxidized phospholipids 
at 1:50 (clone E06, Avanti Polar Lipids) with 2% NS. Secondary 
antibodies (goat a-ms-Alexa®546 and chicken a-goat-Alexa®594, 
donkey a-rabbitAlexa®488) were diluted 1:500 with 2% NS and 
added to the sections. Nuclei were stained with DAPI (Sigma) 
FigUre 1 | Morphology of cortical microglia and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in young and old healthy mice.  
(a) Iba-1:EGFP reporter mice were stained with anti-EGFP and 30-µm thick sections were analyzed of frontoparietal cortex by confocal microscopy. Representative 
immunofluorescence images (maximum intensity projections) from the neocortex of a 6-month-old (left) and 20-month-old (right) mouse indicate the differences in 
morphology of Iba1-EGFP+ cells (green). Scale bar: 50 µm. In the graph, the normalized values of the 3rd to the 10th Fourier coefficients, calculated as described in 
the manuscript, indicate that the ramification of the microglial processes is higher in young (n = 4) than in old healthy mice (n = 4). (b) Representative images of 
PMT-based detection of fluorescence signals and (c) enzyme-bound NAD(P)H-fluorescence lifetime imaging (FLIM) maps (τ2-maps) in a young (6 months; upper 
row) and old (24 months; lower row) mouse. Scale bar: 50 µm. The τ2-maps of the left column show the false color-encoded fluorescence lifetime τ of enzyme-
bound NAD(P)H at each recorded pixel of the image. NAD(P)H bound to metabolic enzymes are depicted in blue and green (τ2 between 1 and 3 ns), whereas 
NADPH bound to activated NOX enzymes appears in red (τ2 between 3.3 and 3.9 ns, “NOX only” gate) is displayed in the right column of (b).
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at a 1:1,000 dilution in phosphate-buffered saline. Slides were 
analyzed on a Zeiss LSM 710 confocal system.
resUlTs
Differences in the Morphology, but similar 
naDPh Oxidase activation levels in 
cortical Microglia of Young and Old Mice
When analyzing the morphology of microglia in Iba-1-EGFP 
reporter mice by immunofluorescence microscopy in various 
age cohorts, we noticed striking differences between young and 
old individuals. While the majority of microglia in mice at the 
age of 6  months displayed a ramified, surveilling morphology 
in the cortex, we noted that those cells in mice between 18 and 
24 months of age had short, blunt processes, suggesting a more 
activated phenotype (Figure 1A). Using our previously published 
algorithm based on discrete Fourier coefficients (17), we found 
a higher ramification of the microglial processes in young mice 
(n =  122 cells) than in old mice (n =  83 cells) as indicated by 
all Fourier coefficients up to the 10th rank, especially by the 3rd 
Fourier coefficient (graph in Figure 1A).
The detection of these morphological differences in micro-
glia between various young and aged mice prompted us to 
FigUre 2 | Continued
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FigUre 2 | Continued  
Elevated NOX activity in the cortex of aged APPE693Q mice. Representative images of areas with elevated (a) and low (b) NOX enzymes activation are both found in 
old APPE693Q mice with established cerebral amyloid angiopathy (CAA). PMT-based detection of fluorescence signals [left column (a,b) dextran–rhodamine in red 
and iba1+ cells in green] in a 24-month-old APPE693Q mouse. Scale bar: 50 µm. The corresponding τ2-maps of the middle column show the false color-encoded 
fluorescence lifetime τ of enzyme-bound NAD(P)H at each recorded pixel of the image. NAD(P)H bound to metabolic enzymes are depicted in blue and green (τ2 
between 1 and 3 ns), whereas nicotinamide adenine dinucleotide phosphate (NADPH) bound to activated NOX appears in red (τ2 between 3.3 and 3.9 ns, “NOX 
only” gate) is displayed in the right column of (a,b). (c) Quantification of the NOX activation area within, i.e., ratio of the area of NOX only gate to the total tissue 
area, 4.9 ± 2.0% (n = 14 fields of view of 5 mice with 2–4 fields of view per mouse) in APPE693Q mice compared to 1.1 ± 0.7% (n = 10 fields of view of 4 mice with 
1–4 fields of view per mouse) and 1.0 ± 0.9% (n = 8 fields of view of 3 mice with 2–3 fields of view per mouse) in healthy controls (old and young, respectively). At 
least 3 mice per group and 2–4 imaging fields per mouse were analyzed. For statistic evaluation, we applied the ANOVA test (**p < 0.01). (D) The τ2 NAD(P)
H-fluorescence lifetime imaging (FLIM) map shows a specific bilayered pattern in the proximity of the vasculature of APPE693Q mice. Scale bar: 25 µm.  
(e) Representative immunofluorescence image within the cortex of patients with CAA showing strong reactivity with the E06 antibody recognizing oxidized 
phospholipids in areas with astrogliosis (stained with anti-GFAP antibody) Scale bar: 50 µm, compared to normal appearing tissue from patients with CAA (shown in 
insets). Scale bar: 50 µm.
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investigate whether they are actually accompanied by differ-
ences in the functionality of these cells. This was performed 
by making use of our previously established method of in vivo 
FLIM (20). The method uses a time-correlated single-photon 
counting device in order to detect the endogenous fluorescence 
lifetime of NAD(P)H, as a differential indicator for the activ-
ity of metabolic enzymes as well as for NOX enzyme activa-
tion in tissue. In combination with PMT-based detection of 
fluorescence signals (Figure 1B), we are able to allocate NOX 
enzyme activation to certain neocortical regions and cell types. 
By applying these techniques in the neocortex of Iba1-EGFP 
mice injected with dextran–rhodamine, we neither detected 
significant differences in the overall activation state of NOX-
dependent enzymes nor an increase in NOX enzyme activation 
specifically in Iba-1+ cells in aged mice (Figure  1C). Taken 
together, this indicates a comparable level of metabolic activity 
of NOX enzymes in young and old mice.
locally elevated nOX activity in the 
cortex of aged aPPe693Q Mice and Oxidized 
Phospholipids in Patients with caa
Next, we aimed to investigate microglia activation in an 
aging-associated disease. We chose an age-dependent model of 
congophilic Aβ CAA. In this model, transgenic mice (APPE693Q 
mice) overexpress E693Q-mutated human APP under the con-
trol of the neuron-specific Thy1 promoter element (19, 21, 22). 
Mice with the APPE693Q mutation exhibit glial reaction 
and neuronal apoptosis in certain areas of the brain without 
extensive presence of Aβ plaques in the parenchyma. However, 
APPE693Q mice display fibrillary Aβ at the vessel walls leading to 
an amyloid angiopathy (starting at an age of 9 months), causing 
hemorrhagic strokes and dementia in aged mice. In order to 
monitor microglia activity in vivo, we crossed the APPE693Q mice 
with Iba1-EGFP mice (18).
We analyzed the activation of NOX enzymes in the frontopa-
rietal neocortex by intravital microscopy. For visualization of 
the vasculature, mice were injected with dextran–rhodamine 
prior to imaging. NAD(P)H-FLIM revealed heterogeneous 
local elevations in NOX activity in APPE693Q mice, and an overall 
elevation of NOX enzyme activity in the tissue was appar-
ent. This effect could be mainly attributed to focal spots with 
elevated NOX activity (Figure 2A), which occurred near areas of 
normal appearing tissue with no elevation in NOX activity. Age-
matched control mice did not exhibit tissue regions of elevated 
NOX activity (Figure  2B), as reflected in the quantification 
of the overall percentage of NOX-signal present in the tissue 
(Figure  2C). The mean area of NOX enzyme activation was 
4.9 ± 2.0% (n = 5 mice) in APPE693Q mice older than 20 months. 
In contrast, aged-matched wild-type controls had only a mean 
of 1.1 ± 0.9% (n = 4 mice) NOX enzyme activation area, a value 
comparable with young wild-type mice: mean =  1.0 ±  0.9% 
(n = 3 mice) and with young APPE639Q mice: mean = 0.8 ± 0.6% 
(n = 1 mouse) (Table 1). Regarding the distribution and range, 
we found that elevated NOX activation was enhanced in the 
immediate vicinity of blood vessels of APPE693Q mice. The activa-
tion appeared in a layered pattern around the vessels: besides 
the endothelium being strongly activated, we also detected other 
activated structures in the tissue neighboring the endothelia; 
frequently, these structures were found to run parallel to the 
vessels (Figure 2D). Having demonstrated the overactivation of 
NOX, we next addressed the question to what extent this NOX 
activity affects the CNS tissue in terms of oxidative distress. We 
therefore stained CNS tissue of patients with CAA by histology, 
using an antibody (E06) that recognizes the phosphocholine 
headgroup of oxidized phospholipids (23) in combination with 
an anti-GFAP antibody labeling astrocytes. Consistent with our 
results regarding elevated NOX activation in the APPE693Q mouse 
model, we found a strong focal presence of oxidized phospho-
lipids, localized in areas with an astrogliosis as displayed by 
GFAP immunoreactivity, compared to normal appearing tissue 
in patients with CAA (Figure 2E, n = 4).
Minor role of Microglia as cellular 
sources of activated nOX in aged 
aPPe693Q Mice and in Patients with caa
In order to further identify the cellular source of NOX activity 
in heterozygous APPE693Q mice, we analyzed aged APPE693Q:Iba1-
EGFP mice by intravital NAD(P)H-FLIM. Microglia were 
identified based on their EGFP fluorescence and vessels identi-
fied by the presence of dextran–rhodamine (Figure  3A, left 
panel). By using the EGFP-signal for masking the image of the 
NAD(P)H-fluorescence lifetime data (Figure 3A, right panel), 
 FigUre 3 | Continued
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we were able to determine the levels of NOX activation specifi-
cally in microglia (Figure 3B). This “gating” strategy revealed 
that only a minor fraction (mean =  1.6 ±  0.8%; n =  3 mice) 
of the total NOX enzymes activity actually originated from 
microglia, whereas the major fraction arouse from other cel-
lular sources in the parenchyma. Moreover, when we analyzed 
the activation state of the microglia population, we found NOX 
enzyme activity in only ~2% of these cells (mean = 1.7 ± 1.4%; 
n = 3 mice, see Table 1). Taken together, these results indicate 
a minor relevance of microglia in the generation of ROS in the 
APPE693Q mouse model and imply other, yet undefined, cells as 
main contributors.
Similar to our results regarding microglial NOX activation in 
the APPE693Q mouse model, we found only low expression levels of 
p47 (a cytosolic subunit present in all NOX enzymes) in cells with 
microglial morphology as compared to blood-derived immune 
cells such as neutrophil granulocytes or macrophages/monocytes 
(Figure 3C, n = 4) in patients with CAA.
Major contribution of astrocytes to 
activated nOX in aged aPPe693Q Mice
Using immunofluorescence histology and intravital NAD(P)
H-FLIM, we previously found NOX1-expressing astrocytes as 
contributors to NOX enzyme overactivation in the context of 
chronic neuroinflammation (17). Based on that, we hypoth-
esized that astrocytes may also contribute to NOX enzyme 
activation observed in APPE693Q mice. In order to identify 
further cellular sources of NOX in the cortex of these mice, we 
performed intravital NAD(P)H-FLIM after local staining with 
sulforhodamine 101 (SR101). Astrocytes were identified based 
on their SR101 fluorescence (Figure  4A, left panel), which 
was used to mask the corresponding NAD(P)H-fluorescence 
lifetime maps (Figure  4B, left panel) and, thus, to determine 
the NOX activation levels in these cells (Figure 4B, right panel). 
By “gating” the NAD(P)H-FLIM maps in this way, we identified 
SR101 labeled cells (astrocytes) to be major cellular contribu-
tors to the NOX activation signal in the cortex of aged APPE693Q 
mice (mean = 37.9 ± 2.1%; n = 2 mice).
In order to verify this finding using immunofluorescence 
histology, we stained brain cortex sections from aged APPE693Q 
mice with antibodies against the Noxo1, a membrane-bound 
subunit of NOX1. While NOX2 is mainly expressed in phago-
cytic cells, other NOX enzymes prevail in other cell types (3, 17). 
Consistent with our intravital data, we could detect an enriched 
membrane-bound Noxo1 signal, co-localizing with processes of 
astrocytes (Figures 4C,D). Taken together, our data suggest that 
the observed bi-laminar NOX activation pattern in APPE693Q mice 
consists of an inner endothelial NOX activation and an outer 
astrocytic NOX activation layer.
FigUre 3 | Minor role of microglia as cellular sources of activated NOX in APPE693Q mice and patients with cerebral amyloid angiopathy (CAA). Fluorescence 
intensity images of the cortex of a Iba1-EGFP-APPE693Q mouse (a) and corresponding τ2 NAD(P)H-fluorescence lifetime imaging (FLIM) maps of the whole tissue 
area (b) were compared to determine the contribution of microglia to the NOX activation signal. We performed an overlay of the two images, as in (a,b), and 
analyzed the NAD(P)H-FLIM signal at the areas of the Iba-1+ cells (green). The τ2 NAD(P)H-FLIM images depict the normalized area of NOX activation in relation  
to the total cellular area in the Iba-1+ cell subsets: mean 1.6 ± 0.8% out of 3 mice; (2–4 fields of view per mouse). Scale bar: 50 µm. (c) Representative 
immunofluorescence image within the cortex of patients with CAA showing enriched p47 at the membrane of blood-derived innate immune cells but not in cells  
with microglial morphology (white arrowheads) (n = 4 patients. Scale bar: 50 µm).
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DiscUssiOn
Age-related changes in immune responses, commonly known 
as immunosenescence, are increasingly moving in the focus of 
immunological research. Immunosenescence is a multifactorial 
phenomenon caused, among other factors, by the diminished 
potential of hematopoietic stem cells to self-renew (24), age-
dependent impairment of antigen-presenting cells (25), a 
reduction of T cell (26) and B cell repertoire and numbers (27), 
causing a decline in adaptive immunity (28). A reduction in 
numbers of phagocytes has been described in aged individuals 
(29), along with an impaired functionality, which has been sug-
gested to reflect the adaptation to age-associated changes in their 
environment (30).
On a molecular level, an age-related deficiency in NOX2 has 
been recently shown to result in a reduced suppressive function 
in aged CD8+ regulatory T cells (31), leading to inflammation 
and tissue destruction. Whether changes in NOX activity also 
occur in other immune subsets during aging, especially in 
phagocytic cells, which are known to express NOX2 at high 
levels, is not known. By analyzing the changes in fluorescence 
lifetime of NAD(P)H as a means to analyze NOX activation 
in vivo, we recently demonstrated that NOX enzyme overacti-
vation in cerebral phagocytes contributes to oxidative distress 
associated with chronic neuroinflammation. Here, we com-
pared the activation of microglia in young versus aged mouse 
cohorts. We found a striking difference in microglia morphol-
ogy between the two groups. While the majority of those cells 
FigUre 4 | Continued
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FigUre 4 | Continued  
Astrocytes are major cellular sources of activated NOX in APPE693Q mice. Similar to Figure 3, fluorescence intensity images of the cortex of a APPE693Q mice labeled 
with sulforhodamine 101 (SR101) (a) and corresponding τ2 NAD(P)H-fluorescence lifetime imaging (FLIM) maps of the whole tissue area (b) were correlatively 
analyzed to measure the contribution of SR101+ cells (mainly astrocytes) to the NOX activation signal. We performed an overlay of the two images and analyzed the 
NAD(P)H-FLIM signal at the areas of SR101 signal (red). The τ2 NAD(P)H-FLIM images depict the normalized area of NOX activation in relation to the total cellular 
area in the SR101 labeled cell subsets: mean 37.9 ± 2.1% out of 2 mice; with 2–3 fields of view per mouse. Scale bar: 50 µm. (c) Representative 
immunofluorescence image within the cortex of a 20-month-old APPE693Q mouse indicating the distribution of Noxo1 (subunit of NOX1, red) and GFAP signal 
(green). Nuclei are stained with DAPI (blue). Scale bar: 50 µm. White box marks inset displayed in (D).
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in young mice showed a ramified morphology typical of a 
surveilling behavior, microglia in old mice typically exhibited 
an activated phenotype characterized by shorter processes. 
Our findings are in line with a previous report in mice (32), 
describing similar changes in morphology. Moreover, a recent 
study has confirmed similar age-dependent changes in human 
microglia (33).
However, none of the previous studies functionally analyzed 
microglia in different age cohorts in  vivo. We chose to take 
NOX enzyme activation as a functional readout for microglia 
activation. Despite the obvious differences in morphology, we 
could not detect differences between young and old individu-
als, when comparing NOX activation by NAD(P)H-FLIM in 
the cerebral cortex of mice. In old and young healthy mice, 
there was also no elevated NOX enzyme activation in the CNS 
tissue, arguing against a chronic low-grade tissue inflamma-
tion, which has been associated with immunosenescence, at 
least in microglia.
Next, we aimed to investigate NOX activation in cerebral 
phagocytes during age-related neurodegenerative disease. AD, 
a fatal neurodegenerative condition, is one of the most com-
mon causes of dementia in aged. Major pathological changes 
are the deposition of extracellular amyloid β (Aβ) peptide 
plaques and formation of neurofibrillary tangles, which con-
sist of the microtubule protein tau, in the CNS tissue. In the 
patients, neuronal dysfunction progressively leads to cognitive 
impairment and loss of memory. While extensive research has 
been performed to elucidate the role of amyloid deposits in 
AD, the role of inflammation in the brain has only recently 
become appreciated. Microglia are in the focus of interest, 
especially during disease progression. Aβ not only aggregates 
in neuronal parenchyma but can also accumulate on blood 
vessel walls, this condition is named CAA and can cause 
hemorrhagic strokes and dementia. We found elevated levels 
of oxidized phospholipids by immunofluorescence in cerebral 
tissue of patients with CAA, suggesting ongoing tissue damage 
by oxidative distress in areas with pronounced astrogliosis. We 
used a mouse model of CAA in order to analyze NOX enzyme 
activity in vivo. In line with the cerebral angiopathy prevailing 
in this mouse model, we found a strong activation of NOX in 
tissue areas around the blood vessels in a typical bilayered pat-
tern. However, our analyses did not show significant elevated 
NOX enzyme activity in microglia, but rather in other CNS 
cells such as astrocytes. We could confirm this hypothesis by 
performing intravital NAD(P)H-FLIM in APPE639Q mice in 
which astrocytes were labeled by sulforhodamine 101, in which 
we found that more than a third of overactivated NOX enzymes 
are associated with astrocytes. By histology, the expression of 
the NOX1-subunit Noxo1 was partly localized in GFAP+ cells, 
underlining the role of astrocytes as contributors to the elevated 
NOX enzyme activity in the tissue. Further cellular sources of 
NOX enzyme activation may include endothelial cells that 
have been shown to express NOX4 (34) or pericytes and vas-
cular smooth muscle cells. However, these results extend our 
previous findings, which identified astrocytes as main source 
of oxidative stress in chronic neuroinflammation, especially 
when peripheral immune cells were not abundant in the CNS 
parenchyma during later stages of the disease (17). It should 
be noted that the level of NOX activation measured in the 
CAA model is around three times lower than in experimental 
autoimmune encephalomyelitis (EAE) (14) and even more in 
a murine glioblastoma model (16), where up to one-third of 
the CNS tissue shows NOX activity. This finding supports the 
idea of a rather low-grade chronic process occurring during 
neurodegenerative diseases, in contrast to an overt inflamma-
tory response. However, a continued—rather low-level—ROS 
production over time can exceed the anti-oxidative capacity of 
the tissue and lead to a slow, but progressive tissue destruction. 
Hence, we expect the ROS production in CAA to be in the 
pathologic range, i.e., >100 nM, but rather low as compared to 
the ROS concentrations found in chronic neuroinflammation 
of ~200 μM (14). Intravital NAD(P)H-FLIM reveals parallels in 
the mechanisms between autoimmune-mediated chronic neu-
roinflammation and primary neurodegenerative diseases. Our 
data point to astrocytes as important cellular players, which 
are able to maintain a state of local low-grade inflammation in 
the CNS tissue via extracellular ROS production. It should be 
emphasized at this point that by detecting NOX activity, our 
method is not suitable for measuring intracellular ROS produc-
tion (~1–10  nM), e.g., resulting from free radicals generated 
in the mitochondrial respiratory chain. Rather, it focuses on 
the massive (physiologic and pathologic) production of extra-
cellular ROS, for which the NADPH oxidase family plays a 
central role.
Interestingly, the specific pattern of NOX activation we found 
in the tissue of the CAA model differed from the one we had 
previously detected in lesions of mice with EAE or glioma. 
A specific NOX enzyme signal was present in the endothelial 
layer as well as in the vicinity of the vasculature. However, the 
latter did not originate from microglia in aged APPE693Q mice. 
There is increasing evidence in the literature that Aβ causes an 
impairment of microglia function (35). It remains to be tested 
whether our findings can be extended to other Aβ aggregation 
forms as seen, e.g., in plaques and to other microglial functions. 
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In addition, it will be important to address the question if locally 
enhanced oxidative distress precedes the formation of Aβ aggre-
gates in the tissue, or if it is a consequence of this process.
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